DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Operating Income Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual operating income in 2023 was 92.15 Million TWD , down -24.58% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly operating income in 2024 Q3 was 20.27 Million TWD , down -46.02% from previous quarter.
  • DIVA Laboratories, Ltd. reported an annual operating income of 122.18 Million TWD in 2022, up 394.82% from previous year.
  • DIVA Laboratories, Ltd. reported an annual operating income of 24.69 Million TWD in 2021, down -57.92% from previous year.
  • DIVA Laboratories, Ltd. reported a quarterly operating income of 34.21 Million TWD for 2024 Q1, up 35.87% from previous quarter.
  • DIVA Laboratories, Ltd. reported a quarterly operating income of 37.55 Million TWD for 2024 Q2, up 9.76% from previous quarter.

Annual Operating Income Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Operating Income of DIVA Laboratories, Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 92.15 Million TWD -24.58%
2022 122.18 Million TWD 394.82%
2021 24.69 Million TWD -57.92%
2020 58.68 Million TWD -9.16%
2019 64.6 Million TWD 0.0%

Peer Operating Income Comparison of DIVA Laboratories, Ltd.

Name Operating Income Operating Income Difference
BIONET Corp. 84.69 Million TWD -8.807%
Genetics Generation Advancement Corp. 18.57 Million TWD -396.081%
Welgene Biotech Co.,Ltd. -4.25 Million TWD 2263.7%
Puriblood Medical Co., Ltd. -50.4 Million TWD 282.83%
TFBS Bioscience Inc. -4.45 Million TWD 2169.436%